Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion type Assertion NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_head.
- NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion description "[We show here, using in vitro receptor autoradiography, a NPY receptor incidence of 85% in primary human breast carcinomas (n = 95) and of 100% in lymph node metastases of receptor-positive primaries (n = 27), predominantly as Y(1) subtype, whereas non-neoplastic human breast expressed Y(2) preferentially.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_provenance.
- NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion evidence source_evidence_literature NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_provenance.
- NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion SIO_000772 11389101 NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_provenance.
- NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion wasDerivedFrom befree-20150227 NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_provenance.
- NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_assertion wasGeneratedBy ECO_0000203 NP596067.RAogNOE6NcQwj2RJ0avev-WuIK16Fk_R7hnJPcHqkASs8130_provenance.